Fig. 1: Study scheme of patient cohort.
From: Clinical and genomic features of Chinese lung cancer patients with germline mutations
Patients diagnosed with lung caner went through targeted sequencing as part of clinical care from November 2017 to August 2018 were included for further analysis. NGS next generation sequencing. WBC white blood cells. ACMG American college of medical genetics and genomics, NSCLC non-small cell lung cancer, SCLC small cell lung cancer, P/LP pathogenic or likely pathogenic.
